Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- The "mRNA Vaccines and Therapeutics Market by Vaccine Type, Treatment Type, Vaccine Manufacturing, Application, End-user, and Region 2024-2032" report has been added to ResearchAndMarkets.com's offering.The global mRNA vaccines and therapeutics market size reached US$ 57.7 billion in 2023. Looking forward, the market is expected to reach US$ 72.7 billion by 2032, exhibiting a growth rate (CAGR) of 2.6% during 2023-2032. The development and acceptance of mRNA-based ...

Moderna, Inc. (NASDAQ:MRNA) Piper Sandler 36th Annual Healthcare Conference December 5, 2024 10:30 AM ET Company Participants Stephane Bancel - Chief Executive Officer Conference Call Participants Ted Tenthoff - Piper Sandler Ted Tenthoff Good morning, everyone. My name is Ted Tenthoff. I'm the senior private tech analyst at Piper Sandler. And before I begin, I am required to point out certain disclosures regarding the relationship between Piper and our next presenting company, Moderna, which are listed bot ...

Moderna, Inc. (NASDAQ:MRNA) 7th Annual Evercore ISI HealthCONx Conference Call December 4, 2024 1:20 PM ET Company Participants Lavina Talukdar - Senior Vice President and Head of Investor Relations Conference Call Participants Cory Kasimov - Evercore ISI Cory Kasimov Good afternoon, everyone. I'm Cory Kasimov, one of the senior biotech analysts here at Evercore ISI. It's my pleasure to host our next session with Moderna. And as you can see, we have Lavina Talukdar, the Senior Vice President and Head of Inv ...

KEY TAKEAWAYSModerna shares surged further Friday, a day after a senior executive made bullish comments at a healthcare conference about the vaccine maker's pipeline and cash position.Moderna expects to become self-funding by 2028, head of investor relations Lavina Talukdar said at the Jefferies London Healthcare Conference.Moderna stock is down almost 60% this year, however, and—like other vaccine makers—was hit recently by President-elect Donald Trump's nomination of vaccine sceptic Robert F. Kennedy Jr. ...

Moderna, Inc. (NASDAQ:MRNA) Jefferies London Healthcare Conference November 21, 2024 9:00 AM ET Company Participants Lavina Talukdar - IR Conference Call Participants Michael Yee - Jefferies Michael Yee Good afternoon everyone. Thank you for joining us on the next session. This afternoon, we have the pleasure of having Moderna here with us and up on the front is the Head of Investor Relations, who everybody knows, Lavina Talukdar. Thank you for joining us. I would say quite a timely discussion because there ...

Moderna, Inc. (NASDAQ:MRNA) Jefferies London Healthcare Conference November 21, 2024 9:00 AM ET Company Participants Lavina Talukdar - IR Conference Call Participants Michael Yee - Jefferies Michael Yee Good afternoon everyone. Thank you for joining us on the next session. This afternoon, we have the pleasure of having Moderna here with us and up on the front is the Head of Investor Relations, who everybody knows, Lavina Talukdar. Thank you for joining us. I would say quite a timely discussion because there ...

Last week, some large European and U.S. vaccine maker stocks fell in reaction to Robert F. Kennedy Jr.’s nomination to lead the Department of Health and Human Services.Including Moderna Inc MRNA, several stocks witnessed a decline as Kennedy has been known to be against vaccines and has a track record of making false claims about vaccines, including the debunked idea that they cause autism.Goldman Sachs hosted an investor lunch with Moderna CEO Stéphane Bancel, President Stephen Hoge, and Lavina Talukdar, S ...

Moderna, Inc. (NASDAQ:MRNA) Guggenheim's Inaugural Healthcare Innovation Conference November 12, 2024 10:00 AM ET Company Participants Stephen Hoge - President Conference Call Participants Evan Wang - Guggenheim Securities Evan Wang [Call Starts Abruptly] Inaugural Health Innovation Conference. I'm Evan Wang, one of the senior biotech analysts at Guggenheim. I'm joined by Stephen Hoge, who is Moderna's President, Head of R&D and now Head of Commercial. I appreciate you being here, Stephen. I'm glad you've a ...

ToplineStocks linked to vaccine developers such as Moderna, Pfizer and Novavax tanked in the leadup to market close Thursday, tumbling after reports surfaced that President-elect Donald Trump would select vaccine skeptic Robert F. Kennedy Jr. as the head of the Department of Health and Human Services.Trump announced his pick Thursday afternoon. (Photo by Tom Brenner for The Washington Post via Getty ... [+] Images)The Washington Post via Getty Images Key FactsTrump confirmed his selection of RFK Jr. on Thur ...

Moderna, Inc. (NASDAQ:MRNA) UBS Global Healthcare Conference November 13, 2024 6:30 PM ET Company Participants Jamey Mock - Chief Financial Officer Conference Call Participants Eliana Merle - UBS Eliana Merle Good afternoon, everyone. Thank you for joining us at the UBS Healthcare Conference. I'm Eliana Merle. I'm one of the biotech analysts here at UBS. Very happy to have Moderna here with us today for fireside chat. Joining us from Moderna is Jamey Mock, Chief Financial Officer. Jamey, thank you so much f ...